Scientifically reviewed by the Flore science team. Every study referenced below is cited with its primary source and linked to PubMed. Where the human evidence is early-stage, we say so.
You bought the panel for your skin, your joints, or your sleep. But something else may be happening every time you step in front of that red glow — something researchers have only recently started to map.
Red light therapy appears to alter the gut microbiome.
Not as a side effect. Not incidentally. As a direct result of what red and near-infrared light does to your cells, your immune system, and the environment your gut bacteria live in. Scientists even coined a term for it in 2019: photobiomics — the study of how light can reshape the microbial communities that influence your health.
This is new science. It’s also real science. Here’s what it shows, what it doesn’t, and why it matters for anyone trying to actually improve their gut health.
What Is Red Light Therapy Doing Inside Your Body?
Red light therapy — more precisely called photobiomodulation (PBM) — works by delivering specific wavelengths of light (typically 630–850 nanometers) to your cells. Those photons are absorbed by an enzyme inside your mitochondria called cytochrome c oxidase, the final enzyme in your cell’s energy production chain.
Here’s what happens next:
Nitric oxide — a molecule that builds up under stress and inflammation — tends to clog cytochrome c oxidase, slowing ATP production and leaving cells energy-deprived. Red light photons dislodge that nitric oxide, restoring electron transfer, boosting ATP synthesis, and triggering a cascade of downstream effects:
- Reduced inflammation — pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) drop significantly
- Macrophage reprogramming — immune cells shift from pro-inflammatory (M1) to anti-inflammatory (M2) state
- Oxidative stress normalization — in inflamed tissue, pathological reactive oxygen species decrease
- Circadian re-entrainment — light is the primary signal your body uses to set its internal clock
Every one of these effects has a direct implication for your gut.
The Gut Connection: How Light Reshapes Your Microbiome
Your gut microbiome doesn’t exist in isolation. It’s exquisitely sensitive to its environment — the inflammatory tone of the mucosal lining, the integrity of the intestinal barrier, the circadian rhythm of the gut epithelium. Change those conditions and you change which bacteria thrive.
This is the mechanism researchers believe connects red light therapy to microbiome changes. It’s not that photons are directly killing or stimulating specific bacterial species. It’s that PBM changes the environment your bacteria live in — and that environmental shift favors beneficial strains over pathobionts.
The peer-reviewed evidence is still early-stage, but it is building. A growing body of studies — reviewed in the 2019 “photobiomics” paper that named the field — links photobiomodulation to measurable shifts in gut microbial communities, and the literature has continued to expand since.
What the Research Has Found
Specific bacterial changes documented in animal and early human studies:
- Akkermansia muciniphila — increases with PBM. This is the bacterium most strongly associated with gut lining integrity and metabolic health. It’s one of the most clinically targeted strains in precision probiotic work.
- Faecalibacterium prausnitzii — increases. Your primary butyrate producer, a short-chain fatty acid that feeds the gut lining and regulates inflammation.
- Roseburia — increases. Another butyrate producer associated with mucosal health and reduced intestinal permeability.
- Firmicutes:Bacteroidetes ratio — shifted toward a healthier balance in a retrospective microbiome analysis of Parkinson’s patients who received a 12-week PBM protocol (Bicknell et al., 2022, n=12): the average ratio fell from 4.60 before treatment to 1.58 after, with 9 of 12 participants improving.
- Proteobacteria and pathobionts — decrease in inflammatory disease models.
A 2019 study (Bicknell et al., Lasers in Medical Science) irradiated the abdomens of healthy mice with red (660 nm) or near-infrared (808 nm) light over a two-week period. Infrared PBM — but not red light — produced a significant increase (p < 0.001) in Allobaculum, a genus associated with a healthy microbiome, by day 14, alongside a measurable shift in overall microbial diversity. It was one of the first controlled demonstrations that light applied to the abdomen can reshape gut bacteria.
The Tight Junction Effect
One of the most clinically significant effects of PBM on the gut is its impact on intestinal permeability — what people commonly call “leaky gut.”
The tight junction proteins that seal your gut lining — occludin, claudin, ZO-1 — are degraded by chronic inflammation. TNF-α and IL-6, the same cytokines PBM reliably reduces, are primary drivers of tight junction breakdown. Restore the inflammatory environment and the barrier starts to repair.
Multiple animal colitis models have demonstrated improved tight junction protein expression following PBM treatment. The mechanism is clean: less cytokine-driven degradation + more ATP for barrier maintenance = a more intact gut wall.
The Circadian Angle
Your gut microbiome runs on a clock. Bacterial populations shift throughout the day in predictable oscillations — and when circadian disruption throws that rhythm off (late nights, screen exposure, erratic sleep), dysbiosis follows.
Red light is one of the most powerful circadian signals available. Morning red light exposure helps re-entrain peripheral circadian clock genes. A re-entrained gut epithelium may secondarily normalize microbiome oscillations — an effect that would compound over time with consistent use.
What the Science Doesn’t Show (Yet)
Honest science includes its own limitations.
Red light penetrates approximately 2–5 centimeters into tissue. Your colon is deeper than that. Transcutaneous PBM applied to the abdomen reaches the gut primarily through systemic effects — reducing whole-body inflammation, improving barrier integrity, altering the circadian environment — rather than by directly illuminating colonic bacteria.
There are also no large-scale randomized controlled trials in humans with gut microbiome sequencing as the primary endpoint. The most substantial human data to date is a retrospective microbiome analysis of 12 Parkinson’s patients — informative, but not a controlled trial. The animal model data is robust, but translation to humans requires confirmation.
This is a field with a strong mechanistic foundation and promising early evidence — not a field with definitive clinical proof. Anyone claiming otherwise is getting ahead of the data.
Why Precision Probiotics Are the Missing Half
Here’s the practical implication of all this.
Red light therapy changes the conditions in your gut. It reduces the inflammatory environment that suppresses beneficial bacteria. It supports the barrier integrity that beneficial anaerobes need to colonize effectively. It may help recalibrate the circadian rhythms that govern microbial populations.
What it doesn’t do is determine which bacteria move into that improved environment.
That’s where most people’s gut health protocols stall. They optimize the environment — through diet, sleep, red light — and then take a generic probiotic that may or may not contain the strains their specific microbiome actually needs.
The strains PBM research shows being upregulated — Akkermansia, Faecalibacterium prausnitzii, Roseburia — are exactly the bacteria a personalized probiotic protocol should be targeting. But knowing which of those you’re deficient in, and in what combination, requires knowing your microbiome.
This is what Flore is built to do.
Flore’s formulas aren’t assembled from published literature or supplier recommendations. They’re built from a Central Intelligence Engine — a clinical database of 9 years of paired microbiome sequencing and symptom resolution data from 40,000+ formulations. When your test results come in, that system queries the outcome patterns of patients with similar microbiome profiles and similar symptoms, and selects the strains with the strongest resolution history for your specific case.
The result: 47.4% of Flore patients resolved their primary symptoms within 6 months. Tracked longitudinally, 92%+ saw improvement by 20 months. That’s not a claim built on theory. It’s a number built on data.
How to Think About Red Light + Precision Probiotics Together
This isn’t about adding more things to your routine. It’s about understanding that the interventions you’re already using can compound — when you know the mechanism.
Red light therapy: reduces gut inflammation, supports tight junction integrity, recalibrates circadian rhythms, creates favorable conditions for beneficial bacteria.
Precision probiotics (matched to your microbiome): delivers the specific strains your gut is actually missing — not a generic blend, not a shelf formula, but the organisms that have resolved similar patterns in similar patients.
One changes the environment. The other determines who moves in.
If you’re already using red light therapy and want to know which strains your microbiome is actually missing, the starting point is a test. Flore builds your formula from there.
The Bottom Line
Red light therapy’s effect on the gut microbiome is real, mechanistically explained, and supported by a growing body of peer-reviewed research. The field even has its own term — photobiomics — introduced in a 2019 review by Liebert, Bicknell and colleagues, and the literature on PBM and the microbiome has grown steadily since.
The summary of what the science shows:
- PBM reduces gut inflammation (TNF-α, IL-1β, IL-6) reliably
- PBM improves intestinal barrier integrity in animal models
- PBM increases beneficial bacteria including Akkermansia and Faecalibacterium prausnitzii
- PBM may recalibrate the circadian rhythms that govern microbial populations
- Large-scale human RCTs are not yet available — this is promising evidence, not definitive proof
The practical takeaway: if you’re using red light therapy for gut health, the question isn’t whether it’s doing something. The question is whether you’re giving your gut the right bacteria to take advantage of what it’s doing.
Flore builds personalized probiotic formulas from your microbiome data — matched against 9 years of real-world outcomes from 40,000+ formulations. Build your formula →
References
- Bicknell B, Liebert A, Johnstone D, Kiat H. Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases. Lasers Med Sci. 2019;34(2):317–327. doi:10.1007/s10103-018-2594-6. PubMed
- Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. “Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome? Photobiomodul Photomed Laser Surg. 2019;37(11):681–693. doi:10.1089/photob.2019.4628. PubMed
- Bicknell B, Liebert A, McLachlan CS, Kiat H. Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study. J Pers Med. 2022;12(1):49. doi:10.3390/jpm12010049. PubMed
These statements have not been evaluated by the Food and Drug Administration. Flore products are not intended to diagnose, treat, cure, or prevent any disease. Outcome data referenced is observational real-world evidence.